As nanotechnology companies continue to develop tiny, microscopic products to support scientific, medical and communications needs, their financial support could explode to enormous levels if they decide to go public.
"As a public company, we can take a somewhat longer-term perspective on earning a return on investment," said John Miller, vice president business development at Arrowhead, which is advised by several professors at the
Nanoparticles work at atomic scales and could produce semiconductors at smaller levels and at lower costs than manufacturing plants, he said.
The potential benefits for medicine, energy and many other fields are enormous, but some scientists are concerned that materials which are harmless at their full size could become toxic at the nanoparticle level.
Mihail Roco, senior adviser for nanotechnology at the
Roco predicts that by 2015, nanotechnology will play a crucial role in $1 trillion worth of products, requiring "two million workers."